Pharma Stability: Insights, Guidelines, and Expertise
Regulatory bodies increasingly demand real-time data for final shelf-life claims. Accelerated data can supplement, but not replace, long-term evidence. If discrepancies occur:
Click to read the full article.
Unlike adult medications, pediatric formulations are often liquid-based or modified for palatability, requiring additional excipients and offering a higher risk of microbial contamination and physical degradation.
Click to read the full article.
Accelerated testing is not always predictive of real-time outcomes. Formulations, packaging materials, excipients, and degradation pathways may behave differently under thermal or humidity stress compared to actual storage conditions. Understanding where and why these mismatches occur is crucial to refining stability strategy.
Click to read the full article.